Karyopharm Therapeutics Inc. (KPTI), a company dedicated to developing innovative cancer treatments, announced on Thursday the appointment of Lori Macomber as Chief Financial Officer, effective January 3. Macomber brings more than two decades of diverse experience to the role, having most recently served as the CFO of Legend Biotech Corporation. Her career includes significant leadership positions at Ametek PDS, Cello Health, Eli Lilly and Company, and Pfizer.
The material has been provided by InstaForex Company - www.instaforex.com
The material has been provided by InstaForex Company - www.instaforex.com